Please try another search
For the nine months ended 20 March 2022, Genky DrugStores Co Ltd revenues increased 10% to Y113.77B. Net income applicable to common stockholders decreased 10% to Y3.07B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Total SGA Expenses increase of 6% to Y18.43B (expense), NOP Other expense increase of 40% to Y119.2M (expense).
Period Ending: | Mar 20, 2024 | Dec 20, 2023 | Sep 20, 2023 | Jun 20, 2023 |
---|---|---|---|---|
Total Revenue | 45096 | 46871 | 44854 | |
Gross Profit | 9435 | 9347 | 9211 | |
Operating Income | 2371 | 2016 | 1951 | |
Net Income | 1369 | 1643 | 1444 | 1451 |
Period Ending: | Mar 20, 2024 | Dec 20, 2023 | Sep 20, 2023 | Jun 20, 2023 |
---|---|---|---|---|
Total Assets | 108300 | 107127 | 105912 | |
Total Liabilities | 64709 | 65174 | 65232 | |
Total Equity | 43591 | 41953 | 40680 |
Period Ending: | Mar 20, 2024 | Dec 20, 2023 | Sep 20, 2023 | Jun 20, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review